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Morphological and immunohistochemical analysis of 45 canine mast cell 
tumours was performed to determine whether the proteins examined are useful for 
a more precise description of tumour morphology and a more reliable determina-
tion of the prognosis in patients. Tissue sections were stained according to the 
standard haematoxylin and eosin (HE) technique and with toluidine blue to dem-
onstrate cytoplasmic granules. Immunohistochemical studies were performed, us-
ing the cell markers CD117 (c-kit), p16 and von Willebrand factor (FVIII). In 
CD117 three different staining patterns were observed: (1) membranous reaction, 
(2) intense staining of cytoplasm, and (3) a diffuse, delicate cytoplasmic reaction. 
Von Willebrand antibody was evaluated on the basis of the number of blood ves-
sels stained. p16 expression was evaluated by scoring positive nuclear reaction. 
Positive expression was demonstrated for all examined antigens, but their level of 
expression differed depending on the grades of tumour malignancy. Statistical 
analysis of the results documented a pronounced positive correlation between the 
markers studied and the grade of tumour malignancy (P < 0.001). It was shown 
that each of the cell markers examined represents a useful prognostic indicator for 
patients with mast cell tumours. The calculated correlation coefficients demon-
strate a strong association between the expressions of CD117, FVIII and p16, and 
the histological malignancy of a tumour. 
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Mast cell tumours or mastocytomas (MCT) belong to the most frequently 
diagnosed skin tumours in dogs (Ciaputa et al., 2013). They develop at any age 
and are independent of the dog’s gender. According to Macy (1985), the predis-
posed breeds include Boxers, Bull Terriers, Labrador Retrievers, Pugs and Bos-
ton Terriers. Clinically, mastocytomas exhibit a variable biological behaviour: 
either individual, benign lesions occasionally infiltrating deeper tissues or multi-
ple, malignant tumours spread throughout the body are noted (Patnaik et al., 
1984; Zemke et al., 2001; Hargis and Ginn, 2012). Most frequently, the tumours 
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are accompanied by dermal erythema, pruritus and oedema (the so-called Dar-
ier’s sign), imitating inflammatory reaction, which frequently leads to misdiag-
nosis and erroneously implemented treatment. The phenomenon is linked to mast 
cell degranulation and release of inflammatory mediators to surrounding tissues 
(Hargis and Ginn, 2012). 
Microscopic evaluation most frequently employs the histological grade of 
tumour malignancy described by Patnaik et al. in 1984 (Zemke et al., 2001). It is 
based on the evaluation of tumour invasiveness, the morphology of mast cells 
and the mitotic index (Table 1). Mast cells manifest a tendency to form larger 
clumps, and with an increasing grade of histological malignancy they begin to 
infiltrate deeper tissues. The sublayer of the tumour involves a fibrous or fi-
brovascular tissue with a tendency for hyalinisation and degeneration of collagen 
fibres, frequently with infiltration by eosinophils. 
Table 1 
Grades of histological malignancy in mast cell tumours according to Patnaik et al. (1984) 
Cell morphology Grade 
of 
malig-
nancy 
Shape Cytoplasm Cell nucleus 
Mitotic index Surrounding  tissues 
I round high amount  
of cytoplasm  
with numerous  
granules 
round with  
condensed  
chromatin 
– slight oedema  
and necrosis 
II round to oval,  
occasionally  
giant or spindle-
shaped 
moderate  
amount of  
cytoplasm with  
delicate granules,  
occasionally scanty  
cytoplasm with large, 
hyperchromatic  
granules 
round, with  
loose  
karyoplasm  
and single  
nucleolus,  
less frequently  
double nuclei 
low, 0–2 per  
high power  
field 
regions of  
significant  
tissue oedema  
and necrosis 
III moderate size, 
round, oval or 
spindle-shaped, 
many giant  
cells 
poorly  
distinguished  
cytoplasm  
containing  
poorly visible  
or invisible  
granules 
round, vesicular 
cell nucleus  
with a single  
or multiple  
nucleoli,  
frequent bi-  
or multinuclear 
cells 
high, 3–6 per 
high power  
field 
frequently  
noted: oedema, 
congestion  
and necrosis 
 
The aim of this study was to determine the expression of cell markers, in-
cluding c-kit (CD117), von Willebrand factor (FVIII) and p16, in mast cell tu-
mours of the canine skin. The results have allowed us to determine the morphol-
 IMMUNOHISTOCHEMICAL STUDY OF CANINE MAST CELL TUMOURS 51 
Acta Veterinaria Hungarica 63, 2015 
ogy of tumours more precisely and to evaluate if the proteins examined are help-
ful in predicting the prognosis. Especially, the findings disclosed the density and 
size of blood vessels, which create a network sufficient for the nutrition and oxy-
genation of the tumour. Furthermore, angiogenesis indicates the growth ability, 
invasiveness and metastatic potential of tumours. The CD117 staining pattern 
and the number of labelled nuclei in p16 staining are highly correlated with MCT 
malignancy. Higher MCT grade and blood vessel density indicate increased ma-
lignancy and poorer prognosis. A further objective was to study whether the his-
tological malignancy of tumours observed in haematoxylin and eosin (HE) 
stained specimens was correlated with the expression of p16 and CD117 proteins 
and the number of blood vessels in the tumours. 
 
 
Materials and methods 
The research was conducted on 45 MCT collected in 2011 at the Depart-
ment of Pathology, Wrocław University of Environmental and Life Sciences 
(Wrocław, Poland). The tumours had been excised from dogs of different breeds, 
sex and age. The studies showed that MCT morbidity reached its peak between 7 
and 9 years of age (27 cases), although neoplastic lesions could be detected in 
animals of various ages (ranging from 2.5 to 14 years), in both sexes (20 female 
and 25 male dogs were examined). In this study, the highest number of cases 
were found in American Staffordshire Terriers (n = 8), followed by Labrador Re-
trievers and mongrel dogs (n = 6 of each), Boxers (n = 5), Dachshunds, Golden 
Retrievers and Bernese Mountain dogs (n = 3 cases in each breed), while the re-
maining breeds were represented by single cases. 
Tumour fragments were fixed in 7% buffered formalin for 24 h, then em-
bedded in paraffin blocks. Three to four µm thick paraffin sections were stained 
with haematoxylin and eosin (HE) and with toluidine blue. 
Immunohistochemical studies were performed in 4-µm-thick paraffin sec-
tions placed on silanised slides. Subsequently the sections were cleared in xylene 
and passed through a series of alcohols of a decreasing concentration to water. 
Antigen retrieval was achieved by cooking the slides in citrate buffer (pH 6.0) at 
97 °C for 20 min. Endogenous peroxidase was blocked in 3% hydrogen peroxide 
solution. Subsequently the sections were overlaid with primary antibodies spe-
cific for CD117 (Polyclonal Rabbit Anti-Human CD117, c-kit, catalogue no. 
A4502, diluted 1:100, Dako®), for von Willebrand factor (FVIII) (Polyclonal 
Rabbit Anti-Human von Willebrand Factor, catalogue No. A0082, diluted 1:200, 
Dako®) and for p16 (Monoclonal Rabbit Anti-Human Anti-p16/INK4a Antibody, 
clone EP435Y, diluted 1:200, Merck Millipore). All the specimens were incu-
bated at room temperature for 20 min, then washed in EnVision™ FLEX Wash 
Buffer (20×). After rinsing them, the sections were overlaid with EnVision™ 
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FLEX/HR visualisation system and incubated at room temperature for 20 min. 
The immunohistochemical reactions were developed using a solution of 3,3-
diaminobenzidine tetrahydrochloride (DAB), EnVision™ FLEX DAB + Chro-
mogen (Dako®). Finally, the sections were rinsed in distilled water, the cell nu-
clei were counterstained with haematoxylin and the specimens were dehydrated 
in a series of alcohols. For every marker studied a positive and a negative control 
was included. The positive control involved samples of healthy skin and employ-
ing all the reagents, while the negative control was prepared with PBS instead of 
antibodies. 
In the detection of CD117 three patterns of colour reaction were distin-
guished: the first pattern involved a pronounced membranous reaction and in 
some cells a slight reaction in the cytoplasm, the second pattern was character-
ised by intense but focal cytoplasmic staining, while the third pattern represented 
a diffuse, delicate staining of the entire cytoplasm. Each slide was evaluated on 
the basis of the highest pattern observed in 100 neoplastic cells at the magnifica-
tion of × 400 (Kiupel et al., 2004). During the statistical analysis the 1st, 2nd and 
3rd pattern staining were used as numerical score. 
By immunostaining with von Willebrand factor the stained endothelial 
cells of blood vessels were examined. Initially, the areas most intensely supplied 
with blood vessels (so-called ‘hot spots’) were identified. For each slide, 5 hot 
spot areas at the magnification of × 200 were chosen. The mean value of the ves-
sel count in those five fields was retained as the final value. The statistical analy-
sis was performed on the number of blood vessels. 
Expression of p16 was evaluated using a semiquantitative scale, scoring 
the positive nuclear reaction (0–5%: no reaction [–], 6–25%: weak reaction [+], 
26–50%: moderate reaction [++], > 50%: intense reaction [+++]). In each slide 5 
randomly selected areas were chosen in which labelled cell nuclei were counted. 
During the examination, nuclear and infrequently cytoplasmic reactions were ob-
served (× 400). 
Microphotographs of all examined neoplastic lesions were taken using an 
Olympus BX53 optical microscope (Olympus, Japan), coupled to a ColorView 
IIIu digital camera (Olympus, Japan). 
The results were subjected to statistical analysis using Statistica PL soft-
ware (StatSoft Polska) including the determination of Spearman’s correlation co-
efficient (rho). 
 
Results 
On the basis of HE and toluidine blue staining, the tumours were grouped 
in line with the scale of histological malignancy according to Patnaik et al. 
(1984): 11 tumours represented an MCT of grade I, 21 of grade II and 13 of 
grade III (Fig. 1). 
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Fig. 1. Mast cell tumour staining with haematoxylin and eosin (HE) (a–c) and toluidine blue (d). a. 
Grade I. Round mast cells with abundant cytoplasm and numerous granules. × 400; b. Grade II. 
Round and oval cells with various amounts of cytoplasm and delicate granules. Some cells contain 
double nuclei. × 400; c. Grade III. Polymorphic cell with no visible cytoplasmic granules. Different 
size of nuclei and also multinucleated cells. Visible mitotic figures. × 400; d. Grade II. Dark violet 
mast cells granules, visible on blue background. × 1000 
 
In grade I tumours CD117 demonstrated first-pattern staining in 100% of 
the lesions. On the average, two blood vessels were noted per visual field, in-
cluding 18.1% slides with a single blood vessel, 45.5% slides with two blood 
vessels and 36.4% slides with three blood vessels. Staining for the proliferation 
marker p16 demonstrated weak [+] reaction in 72.7% of the cases, and a moder-
ate reaction [++] in 27.3%. In the group studied, no pronounced reaction for p16 
protein [+++] was noted. Mostly a delicate cytoplasmic reaction was observed, 
with only a few nuclei being stained. 
In case of grade II tumours 47.6% of the lesions manifested the second 
pattern of staining for CD117, while 38.1% exhibited the third and 14.3% the 
first pattern of staining. On the average, four blood vessels were detected per 
visual field, including 57.1% slides with 4, 28.6% with 3 and 14.3% with 5 blood 
vessels. In studies for the detection of p16, 66.7% cases manifested a moderate 
reaction [++], 23.8% cases represented a weak reaction [+], and only in 9.5% 
a b
dc 
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cases was there a pronounced reaction [+++]. Usually about 35% of the nuclei 
were labelled brown, and staining of cytoplasmic location was infrequently ob-
served. 
In all (100%) grade III cases the third-pattern staining of CD117 was noted. 
On the average, five blood vessels were detected per visual field, including 
61.5% cases with 5, 23.1% cases with 6 and 15.4% cases with 4 blood vessels. 
All the slides demonstrated expression of p16 protein at a high level [+++], and 
the visual field was dominated by labelled nuclei. The expression of cell markers 
in different grades of MCT is illustrated in Fig. 2. 
 
Fig. 2. Staining pattern of examined antibodies in all grades of mast cell tumour. (a–c) CD117 ex-
pression pattern was different, depending on malignancy: a. Grade I. Pronounced membranous re-
action is visible in nearly all cells. × 400; b. Grade II. Intense, focal staining of cytoplasm. × 200; c. 
Grade III. Delicate, diffuse staining of cytoplasm. × 400. (d–f) von Willebrand factor expression 
pattern was similar in all cases, the most important difference being in the number of disclosed 
blood vessels: d. Grade I. Two blood vessels are visible. × 200; e. Grade II. Five blood vessels are 
visible. × 200; f. Grade III. Seven blood vessels are visible. × 200. (g–i) p16 expression, stained 
nuclei were taken into account: g. Grade I. Only few cells presented a nuclear staining pattern, 
mostly the cytoplasm was labelled. × 400; h. Grade II. Immunostained nuclei, cytoplasmic reaction 
was weaker than in grade I. × 400; i. Grade III. In most of the cells nuclear reaction was observed. 
× 400 
 
a b c
d e f 
i hg 
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Statistical analysis of the results demonstrated a statistically significant 
(P < 0.001) positive correlation between the grade of tumour malignancy deter-
mined by HE staining and the expression of CD117, FVIII and p16 proteins, as 
well as between individual protein pairs. The correlation coefficient (rho, accord-
ing to Spearman) manifested values > 0.7 for each pair of staining: HE–CD117: 
0.85; HE–FVIII: 0.9; HE–p16: 0.84; CD117–FVIII: 0.89; CD117–p16: 0.72, 
FVIII–p16: 0.78. Thus, the results demonstrate a pronounced relationship be-
tween the cell markers studied. 
 
Discussion 
Canine mastocytoma represents a tumour that remains to be poorly under-
stood despite its very high incidence. This reflects its variable biological behav-
iour and incompletely recognised, probably multifactorial aetiology. 
The factor, which is responsible for the proliferation, differentiation and 
degranulation of mast cells, involves the kit ligand and is termed also as mast 
cell growth factor (MCF) or stem cell factor (SCF). The ligand, located on mast 
cells, binds to the transmembrane receptor of KIT tyrosine kinase (classified as 
CD117) (Webster et al., 2006; Passantino et al., 2008). This involves a protein 
coded by the c-kit proto-oncogen. The role of c-kit mutation has been empha-
sised in the aetiology of mastocytoma. As a result of such mutations the KIT re-
ceptor becomes stably stimulated even in the absence of the ligand (Kiupel et al., 
2004; Morini et al., 2004). Most frequently, mutations of the duplication type 
(ITD – internal tandem duplication) and deletions of exon 11 are detected 
(Zemke et al., 2001; Zemke et al., 2002; Webster et al., 2006), but they are pre-
sent in only 30–50% of dogs carrying grade II or III mastocytoma (Downing et 
al., 2002; Zemke et al., 2002). These results indicate that, apart from the mutated 
c-kit protein, probably also other factors play a significant role in the induction 
of mast cell tumours; however, the mutations are definitely linked to the histo-
logical grade of tumour malignancy. 
Our investigations have corroborated the results obtained by the groups of 
Kiupel, Webster, Zemke and Passantino, which strictly linked the obtained pat-
tern of CD117 staining with the histological malignancy of mastocytoma (Zemke 
et al., 2001; Kiupel et al., 2004; Webster et al., 2006; Passantino et al., 2008). 
Moreover, our results have confirmed the observations of Kiupel et al. (2004) 
and Webster et al. (2006) that the type of reaction pattern makes it possible to 
predict the probability of tumour progression. Low-grade histological tumour 
malignancy is mainly linked to the membranous reaction and insignificant stain-
ing of the cytoplasm, while high-grade malignancy is usually associated with a 
diffuse cytoplasmic reaction. Therefore, despite the apparently low or intermedi-
ate histological malignancy estimated by HE staining (MCT of grade I or II), oc-
casionally quite distinct results can be obtained in anti-CD117 staining. A pro-
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nounced positive correlation with the grade of histological malignancy has been 
demonstrated (estimated in HE staining at the level of 0.85) which confirms the 
important role of the c-kit protein. In studies on grades I and III, 100% of slides 
showed the first and the third pattern of staining, respectively. For tumours of 
grade II malignancy, the results were more divergent: most of the slides mani-
fested the second pattern of staining although reactions of both the first and the 
third types were detected as well. This is thought to be linked to morphological 
heterogeneity of the tumours. In the studies of Northrup et al. (2005) and Kiupel 
et al. (2011) it was shown that subjective evaluation by a pathomorphologist also 
plays an important role. The highly pronounced correlation between the expres-
sions of CD117 and p16 (0.72) points to a strong relationship between the pro-
teins in MCT. This confirms the earlier drawn conclusions on the strict depend-
ence between the CD117 staining pattern, the higher histological malignancy of 
the mast cell tumour and a less favourable prognosis. 
Neoangiogenesis has a key importance in neoplastic processes. Blood ves-
sels of the tumour manifest a number of abnormalities in both structure and func-
tion. The basement membrane and the pericytes may form a few loosely linked 
layers, in which cells can have an irregular shape. The leaky endothelium gives 
rise to haemorrhages and facilitates the passage of tumour cells into the circulation 
(Crivellato et al., 2008). Mast cells show a tendency to accumulate in places of 
new blood vessel formation. The released mediators control the proliferation and 
function of endothelial cells (Metcalfe et al., 1997; Crivellato et al., 2008). Ac-
cording to Crivellato et al. (2008), these mediators include VEGF (vascular en-
dothelial growth factor), FGF-2 (fibroblast growth factor-2), TGF-β (transform-
ing growth factor-β), TGF-α (tumour necrosis factor-α), IL-8, MMP-2 (matrix 
metalloproteinase-2), MMP-9 (matrix metalloproteinase-9), NGF (nerve growth 
factor), PDGF (plateled-derived growth factor), angiopoietin 1, leptin, 
adrenomedullin, tryptase, chymase, histamine and heparin. In addition, mediators 
are produced which aim at the degradation of extracellular matrix (ECM), which 
facilitates the development of metastases and promotes the angiogenetic process 
(Baram et al., 2001). Numerous studies have demonstrated that the higher den-
sity of blood vessels within MCT is connected with a poorer prognosis (Theoha-
rides and Conti, 2004; Crivellato et al., 2008; Strefezzi et al., 2009). 
The present study has corroborated the observations of Ranieri et al. 
(2003), Preziosi et al. (2004) and Strefezzi et al. (2009) that the number of blood 
vessels represents an important aspect of malignancy: an increasing grade of his-
tological malignancy of the tumour was accompanied by a growing density of 
vascular network. Moreover, the statistical analysis of results obtained in the pre-
sent study has demonstrated a pronounced positive correlation at the level of 0.9 
between the grade of malignancy and the expression of FVIII. This confirms that 
in tumours of a higher malignancy grade the cells are better supplied with blood. 
Therefore, it can be concluded that such a supply is linked with evident progres-
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sion of the tumour. Statistical analysis has demonstrated a positive correlation at 
the level of 0.89 between the expressions of FVIII and CD117. The results cor-
roborate the pronounced relationship between the density of blood supply and 
the pattern of CD117 staining and, thus, the histological grade of tumour malig-
nancy. 
The p16 protein, which belongs to the inhibitors of cyclin-dependent 
kinases, controls the passage of cells from G1 into S phase and is considered to 
represent a factor inhibiting the growth of neoplastic cells. Physiologically, ex-
pression of the marker is high in currently non-dividing cells and low in in-
tensely dividing cells. Moreover, the protein acts as a controller of tumour cell 
apoptotic process, in which a decreased expression of p16 induces an increased 
resistance of cells to apoptosis, which may promote their immortality (Rocco and 
Sidransky, 2001; Witkiewicz et al., 2011). DeInnocentes et al. (2009) and Wit-
kiewicz et al. (2011) observed an increased expression of p16 in senescent cells, 
cells with damaged DNA and cells under oncogenic stress. High level of the pro-
tein was shown also in certain neoplastic lesions, first of all in those induced by 
oncogenic viruses as well as in ovarian cancer and in adenocarcinomas of the 
milk gland (DeInnocentes et al., 2009; Phillips et al., 2009; Witkiewicz et al., 
2011). According to DeInnocentes et al. (2009), this is probably linked to genetic 
mutations of deletion type in the p16 gene. Despite several biochemical and ge-
netic studies, the role of the markers remains to be fully clarified while its in-
creased or decreased expression is probably linked to multiple factors (Rocco 
and Sidransky, 2001). 
In our own studies we have demonstrated a very pronounced reaction 
[+++] for p16 in all examined grade III cases and a weak reaction in 72.7% of 
grade I cases, in which less than 25% of the cells proved to be positive. More-
over, the statistical analyses have demonstrated a pronounced correlation at the 
level of 0.84 between the expression of p16 protein and the histological malig-
nancy of tumours evaluated in HE-stained slides. This has allowed us to confirm 
the suggestion that in mast cell tumours the expression of this marker increases 
with the grade of histological malignancy. The correlation coefficient between 
the expression of p16 protein and that of FVIII was found to be 0.78. The results 
indicate a strong interrelationship between the two markers studied: accordingly, 
an increased expression of the p16 protein is associated with both a higher de-
gree of histological malignancy found by HE staining and a higher density of the 
blood vessel network. 
In summary, we can state that each of the cell markers examined repre-
sents a useful prognostic indicator for patients with MCT. The calculated correla-
tion coefficients confirm a strong link between the expressions of CD117, FVIII 
and p16 and the histological malignancy of a tumour. An increased expression of 
the cell markers studied points to a higher likelihood of progression of dermal 
mastocytoma in dogs. 
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